Jena, Germany

Michael Proehl

This inventor holds 1 USPTO granted patent. Top assignee: Friedrich-Schiller-Universitaet Jena. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Proehl: Innovator in Cationic Polymers

Introduction

Michael Proehl is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biocompatible materials through his innovative work on cationic polymers. His research focuses on creating polymers that can selectively interact with specific elements on cell surfaces, which has important implications for medical applications.

Latest Patents

Proehl holds a patent for "Cationic polymers with D-fructose substituents." This invention addresses the challenge of developing novel, biocompatible, and easy-to-produce cationic polymers that exhibit higher selectivity for certain cell types. The patent describes cationic polymers that are covalently bonded with D-fructose, allowing for targeted interactions with cell surfaces.

Career Highlights

Michael Proehl is affiliated with Friedrich Schiller University Jena, where he conducts his research. His work has led to advancements in the understanding and application of cationic polymers in various fields, particularly in biomedicine. He has successfully developed a polymer structure that enhances selectivity and biocompatibility.

Collaborations

Proehl has collaborated with esteemed colleagues such as Christoph Englert and Ulrich Sigmar Schubert. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of polymer science.

Conclusion

Michael Proehl's contributions to the development of cationic polymers with D-fructose substituents highlight his role as an important inventor in the field. His work not only advances scientific knowledge but also has the potential to impact medical applications significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…